authors
- Svatek, Robert S
- Wheeler, Karen
- Sharp, Z Dave
- Livi, Carolina B
- Shu, Zhen-Ju
- Henkes, David
- Curiel, Tyler J
- Ji, Niannian
- de Leon, Essel
- Mukherjee, Neelam Z
- Kabra, Aashish
- Hurez, Vincent
- Nicolas, Marlo
- Michalek, Joel E
- Javors, Martin
Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer.
- Overview
- Identity
- Additional Document Info
- View All
Overview
publication date
- December 18, 2018
published in
- Cancer immunology research Journal
has subject area
- Aged
- Animals
- B7-H1 Antigen
- Cell Proliferation
- Cystectomy
- Disease Models, Animal
- Female
- Humans
- Male
- Mechanistic Target of Rapamycin Complex 1
- Mice
- Mice, Inbred C57BL
- Phosphorylation
- Postoperative Complications
- Programmed Cell Death 1 Receptor
- Ribosomal Protein S6
- Sirolimus
- T-Lymphocytes
- Urinary Bladder
- Urinary Bladder Neoplasms